Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain.

Ved N, Da Vitoria Lobo ME, Bestall SM, L Vidueira C, Beazley-Long N, Ballmer-Hofer K, Hirashima M, Bates DO, Donaldson LF, Hulse RP.

J Physiol. 2018 May 17. doi: 10.1113/JP275067. [Epub ahead of print]

PMID:
29774557
2.

VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis.

Beazley-Long N, Moss CE, Ashby WR, Bestall SM, Almahasneh F, Durrant AM, Benest AV, Blackley Z, Ballmer-Hofer K, Hirashima M, Hulse RP, Bates DO, Donaldson LF.

Brain Behav Immun. 2018 Mar 14. pii: S0889-1591(18)30060-6. doi: 10.1016/j.bbi.2018.03.012. [Epub ahead of print]

3.

Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.

Zeggar S, Watanabe KS, Teshigawara S, Hiramatsu S, Katsuyama T, Katsuyama E, Watanabe H, Matsumoto Y, Kawabata T, Sada KE, Niki T, Hirashima M, Wada J.

Arthritis Rheumatol. 2018 Jul;70(7):1089-1101. doi: 10.1002/art.40467. Epub 2018 May 24.

PMID:
29481735
4.

MicroRNA profiles during galectin-9-induced apoptosis of pancreatic cancer cells.

Okura R, Fujihara S, Iwama H, Morishita A, Chiyo T, Watanabe M, Hirose K, Kobayashi K, Fujimori T, Kato K, Kamada H, Kobara H, Mori H, Niki T, Hirashima M, Okano K, Suzuki Y, Masaki T.

Oncol Lett. 2018 Jan;15(1):407-414. doi: 10.3892/ol.2017.7316. Epub 2017 Nov 1.

5.

Transcriptome analysis in petals and leaves of chrysanthemums with different chlorophyll levels.

Ohmiya A, Sasaki K, Nashima K, Oda-Yamamizo C, Hirashima M, Sumitomo K.

BMC Plant Biol. 2017 Nov 15;17(1):202. doi: 10.1186/s12870-017-1156-6.

6.

Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.

Madireddi S, Eun SY, Mehta AK, Birta A, Zajonc DM, Niki T, Hirashima M, Podack ER, Schreiber TH, Croft M.

J Immunol. 2017 Oct 15;199(8):2721-2728. doi: 10.4049/jimmunol.1700575. Epub 2017 Sep 6.

PMID:
28877989
7.

Dynamics of angiogenesis in ischemic areas of the infarcted heart.

Kobayashi K, Maeda K, Takefuji M, Kikuchi R, Morishita Y, Hirashima M, Murohara T.

Sci Rep. 2017 Aug 2;7(1):7156. doi: 10.1038/s41598-017-07524-x.

8.

Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.

Horio Y, Ichiyasu H, Kojima K, Saita N, Migiyama Y, Iriki T, Fujii K, Niki T, Hirashima M, Kohrogi H.

PLoS One. 2017 Jul 12;12(7):e0180742. doi: 10.1371/journal.pone.0180742. eCollection 2017.

9.

X-ray structure of a protease-resistant mutant form of human galectin-9 having two carbohydrate recognition domains with a metal-binding site.

Yoshida H, Nishi N, Wada K, Nakamura T, Hirashima M, Kuwabara N, Kato R, Kamitori S.

Biochem Biophys Res Commun. 2017 Sep 2;490(4):1287-1293. doi: 10.1016/j.bbrc.2017.07.009. Epub 2017 Jul 4.

PMID:
28687490
10.

Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study.

Tadokoro T, Fujihara S, Chiyo T, Oura K, Samukawa E, Yamana Y, Fujita K, Mimura S, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Iwama H, Niki T, Hirashima M, Masaki T.

Int J Oncol. 2017 Aug;51(2):607-614. doi: 10.3892/ijo.2017.4053. Epub 2017 Jun 23.

PMID:
28656219
11.

Correlation between serum galectin-9 levels and liver fibrosis.

Fujita K, Niki T, Nomura T, Oura K, Tadokoro T, Sakamoto T, Tani J, Yoneyama H, Morishita A, Kuroda N, Arai T, Nishimoto N, Himoto T, Hirashima M, Masaki T.

J Gastroenterol Hepatol. 2018 Feb;33(2):492-499. doi: 10.1111/jgh.13851.

PMID:
28618039
12.

Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells.

Akashi E, Fujihara S, Morishita A, Tadokoro T, Chiyo T, Fujikawa K, Kobara H, Mori H, Iwama H, Okano K, Suzuki Y, Niki T, Hirashima M, Masaki T.

Oncol Rep. 2017 Jul;38(1):506-514. doi: 10.3892/or.2017.5689. Epub 2017 Jun 1.

PMID:
28586026
13.

Galectin‑9 ameliorates fulminant liver injury.

Tadokoro T, Morishita A, Sakamoto T, Fujihara S, Fujita K, Mimura S, Oura K, Nomura T, Tani J, Yoneyama H, Iwama H, Himoto T, Niki T, Hirashima M, Masaki T.

Mol Med Rep. 2017 Jul;16(1):36-42. doi: 10.3892/mmr.2017.6606. Epub 2017 May 18.

14.

VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis.

Jang JY, Choi SY, Park I, Park DY, Choe K, Kim P, Kim YK, Lee BJ, Hirashima M, Kubota Y, Park JW, Cheng SY, Nagy A, Park YJ, Alitalo K, Shong M, Koh GY.

EMBO Mol Med. 2017 Jun;9(6):750-769. doi: 10.15252/emmm.201607341.

15.

Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown.

Ogura S, Kurata K, Hattori Y, Takase H, Ishiguro-Oonuma T, Hwang Y, Ahn S, Park I, Ikeda W, Kusuhara S, Fukushima Y, Nara H, Sakai H, Fujiwara T, Matsushita J, Ema M, Hirashima M, Minami T, Shibuya M, Takakura N, Kim P, Miyata T, Ogura Y, Uemura A.

JCI Insight. 2017 Feb 9;2(3):e90905. doi: 10.1172/jci.insight.90905.

16.

PKN2 is essential for mouse embryonic development and proliferation of mouse fibroblasts.

Danno S, Kubouchi K, Mehruba M, Abe M, Natsume R, Sakimura K, Eguchi S, Oka M, Hirashima M, Yasuda H, Mukai H.

Genes Cells. 2017 Feb;22(2):220-236. doi: 10.1111/gtc.12470. Epub 2017 Jan 19. Erratum in: Genes Cells. 2017 Mar;22(3):328.

17.

Cancer Therapy Due to Apoptosis: Galectin-9.

Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Hirashima M, Masaki T.

Int J Mol Sci. 2017 Jan 1;18(1). pii: E74. doi: 10.3390/ijms18010074. Review.

18.

Semaphorin 3G Provides a Repulsive Guidance Cue to Lymphatic Endothelial Cells via Neuropilin-2/PlexinD1.

Liu X, Uemura A, Fukushima Y, Yoshida Y, Hirashima M.

Cell Rep. 2016 Nov 22;17(9):2299-2311. doi: 10.1016/j.celrep.2016.11.008.

19.

Tagging motor memories with transcranial direct current stimulation allows later artificially-controlled retrieval.

Nozaki D, Yokoi A, Kimura T, Hirashima M, Orban de Xivry JJ.

Elife. 2016 Jul 29;5. pii: e15378. doi: 10.7554/eLife.15378.

20.

Visuomotor Map Determines How Visually Guided Reaching Movements are Corrected Within and Across Trials.

Hayashi T, Yokoi A, Hirashima M, Nozaki D.

eNeuro. 2016 Jun 3;3(3). pii: ENEURO.0032-16.2016. doi: 10.1523/ENEURO.0032-16.2016. eCollection 2016 May-Jun.

21.

Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation.

Abdel-Mohsen M, Chavez L, Tandon R, Chew GM, Deng X, Danesh A, Keating S, Lanteri M, Samuels ML, Hoh R, Sacha JB, Norris PJ, Niki T, Shikuma CM, Hirashima M, Deeks SG, Ndhlovu LC, Pillai SK.

PLoS Pathog. 2016 Jun 2;12(6):e1005677. doi: 10.1371/journal.ppat.1005677. eCollection 2016 Jun.

22.

Flt1/VEGFR1 heterozygosity causes transient embryonic edema.

Otowa Y, Moriwaki K, Sano K, Shirakabe M, Yonemura S, Shibuya M, Rossant J, Suda T, Kakeji Y, Hirashima M.

Sci Rep. 2016 Jun 2;6:27186. doi: 10.1038/srep27186.

23.

Galectin-9: An anticancer molecule for gallbladder carcinoma.

Tadokoro T, Morishita A, Fujihara S, Iwama H, Niki T, Fujita K, Akashi E, Mimura S, Oura K, Sakamoto T, Nomura T, Tani J, Miyoshi H, Yoneyama H, Himoto T, Hirashima M, Masaki T.

Int J Oncol. 2016 Mar;48(3):1165-74. doi: 10.3892/ijo.2016.3347. Epub 2016 Jan 19.

PMID:
26797414
24.

How does the brain solve muscle redundancy? Filling the gap between optimization and muscle synergy hypotheses.

Hirashima M, Oya T.

Neurosci Res. 2016 Mar;104:80-7. doi: 10.1016/j.neures.2015.12.008. Epub 2015 Dec 24. Review.

PMID:
26724372
25.

Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.

Takano J, Morishita A, Fujihara S, Iwama H, Kokado F, Fujikawa K, Fujita K, Chiyo T, Tadokoro T, Sakamoto T, Nomura T, Tani J, Miyoshi H, Yoneyama H, Kobara H, Mori H, Niki T, Hirashima M, Masaki T.

Oncol Rep. 2016 Feb;35(2):851-60. doi: 10.3892/or.2015.4452. Epub 2015 Nov 26.

PMID:
26717877
26.

Association Between Plasma Level of Galectin-9 and Survival of Patients With Drug-Induced Acute Liver Failure.

Rosen HR, Biggins SW, Niki T, Gralla J, Hillman H, Hirashima M, Schilsky M, Lee WM; Acute Liver Failure Study Group.

Clin Gastroenterol Hepatol. 2016 Apr;14(4):606-612.e3. doi: 10.1016/j.cgh.2015.09.040. Epub 2015 Oct 20.

PMID:
26499927
27.

High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals.

Hirashima M, Imamura T, Yano K, Kawamura R, Meta A, Tokieda Y, Nakashima T.

J Biochem. 2016 Feb;159(2):261-70. doi: 10.1093/jb/mvv099. Epub 2015 Oct 15.

28.

Proposed criterion for distinguishing ABO mosaics from ABO chimeras using flow cytometric analysis.

Oda A, Matsuyama N, Hirashima M, Ishii H, Kimura K, Matsukura H, Hirayama F, Kawa K, Fukumori Y.

Immunohematology. 2015;31(1):24-8.

PMID:
26308467
29.

Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest.

Kobayashi K, Morishita A, Iwama H, Fujita K, Okura R, Fujihara S, Yamashita T, Fujimori T, Kato K, Kamada H, Niki T, Hirashima M, Okano K, Suzuki Y, Masaki T.

Oncol Rep. 2015 Oct;34(4):1761-70. doi: 10.3892/or.2015.4197. Epub 2015 Aug 10.

PMID:
26260906
30.

The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux.

Wiersma VR, de Bruyn M, Wei Y, van Ginkel RJ, Hirashima M, Niki T, Nishi N, Zhou J, Pouwels SD, Samplonius DF, Nijman HW, Eggleton P, Helfrich W, Bremer E.

Autophagy. 2015;11(8):1373-88. doi: 10.1080/15548627.2015.1063767.

31.

MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.

Miyata M, Morishita A, Sakamoto T, Katsura A, Kato K, Nishioka T, Toyota Y, Fujita K, Maeda E, Nomura T, Tani J, Miyoshi H, Yoneyama H, Kobara H, Fujiwara S, Nishiyama N, Iwama H, Himoto T, Hirashima M, Masaki T.

Int J Oncol. 2015 Aug;47(2):535-42. doi: 10.3892/ijo.2015.3036. Epub 2015 Jun 5.

PMID:
26060089
32.

Impact of Exogenous Galectin-9 on Human T Cells: CONTRIBUTION OF THE T CELL RECEPTOR COMPLEX TO ANTIGEN-INDEPENDENT ACTIVATION BUT NOT TO APOPTOSIS INDUCTION.

Lhuillier C, Barjon C, Niki T, Gelin A, Praz F, Morales O, Souquere S, Hirashima M, Wei M, Dellis O, Busson P.

J Biol Chem. 2015 Jul 3;290(27):16797-811. doi: 10.1074/jbc.M115.661272. Epub 2015 May 6.

33.

Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo.

Fujita K, Iwama H, Sakamoto T, Okura R, Kobayashi K, Takano J, Katsura A, Tatsuta M, Maeda E, Mimura S, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Yamana Y, Himoto T, Okano K, Suzuki Y, Niki T, Hirashima M, Masaki T.

Int J Oncol. 2015;46(6):2419-30. doi: 10.3892/ijo.2015.2941. Epub 2015 Mar 30.

PMID:
25823465
34.

High-yield preparation of recombinant human α-thrombin for therapeutic use.

Meta A, Hirashima M, Imamura T, Kawamura R, Yano K, Uehara K, Nakashima T.

J Biosci Bioeng. 2015 Oct;120(4):432-7. doi: 10.1016/j.jbiosc.2015.02.001. Epub 2015 Feb 27.

PMID:
25735923
35.

MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis.

Katsura A, Morishita A, Iwama H, Tani J, Sakamoto T, Tatsuta M, Toyota Y, Fujita K, Kato K, Maeda E, Nomura T, Miyoshi H, Yoneyama H, Himoto T, Fujiwara S, Kobara H, Mori H, Niki T, Ono M, Hirashima M, Masaki T.

Int J Mol Med. 2015 Apr;35(4):877-84. doi: 10.3892/ijmm.2015.2092. Epub 2015 Feb 6.

36.

Prospective errors determine motor learning.

Takiyama K, Hirashima M, Nozaki D.

Nat Commun. 2015 Jan 30;6:5925. doi: 10.1038/ncomms6925.

37.

A novel mutation of the GATA site in the erythroid cell-specific regulatory element of the ABO gene in a blood donor with the Am B phenotype.

Oda A, Isa K, Ogasawara K, Kameyama K, Okuda K, Hirashima M, Ishii H, Kimura K, Matsukura H, Hirayama F, Kawa K.

Vox Sang. 2015 May;108(4):425-7. doi: 10.1111/vox.12229. Epub 2014 Dec 30.

PMID:
25557060
38.

Identification of genes associated with chlorophyll accumulation in flower petals.

Ohmiya A, Hirashima M, Yagi M, Tanase K, Yamamizo C.

PLoS One. 2014 Dec 3;9(12):e113738. doi: 10.1371/journal.pone.0113738. eCollection 2014.

39.

Functional modulation of corticospinal excitability with adaptation of wrist movements to novel dynamical environments.

Kadota H, Hirashima M, Nozaki D.

J Neurosci. 2014 Sep 10;34(37):12415-24. doi: 10.1523/JNEUROSCI.2565-13.2014.

40.

Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells.

Wu C, Thalhamer T, Franca RF, Xiao S, Wang C, Hotta C, Zhu C, Hirashima M, Anderson AC, Kuchroo VK.

Immunity. 2014 Aug 21;41(2):270-82. doi: 10.1016/j.immuni.2014.06.011. Epub 2014 Jul 24.

41.

Lateralized sensitivity of motor memories to the kinematics of the opposite arm reveals functional specialization during bimanual actions.

Yokoi A, Hirashima M, Nozaki D.

J Neurosci. 2014 Jul 2;34(27):9141-51. doi: 10.1523/JNEUROSCI.2694-13.2014.

42.

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies.

Madireddi S, Eun SY, Lee SW, Nemčovičová I, Mehta AK, Zajonc DM, Nishi N, Niki T, Hirashima M, Croft M.

J Exp Med. 2014 Jun 30;211(7):1433-48. doi: 10.1084/jem.20132687. Epub 2014 Jun 23.

43.

Precursors of dancing and singing to music in three- to four-months-old infants.

Fujii S, Watanabe H, Oohashi H, Hirashima M, Nozaki D, Taga G.

PLoS One. 2014 May 16;9(5):e97680. doi: 10.1371/journal.pone.0097680. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e103192.

44.

Decomposition of spontaneous movements of infants as combinations of limb synergies.

Kato M, Hirashima M, Oohashi H, Watanabe H, Taga G.

Exp Brain Res. 2014 Sep;232(9):2919-30. doi: 10.1007/s00221-014-3972-3. Epub 2014 May 14.

PMID:
24825825
45.

Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.

Tandon R, Chew GM, Byron MM, Borrow P, Niki T, Hirashima M, Barbour JD, Norris PJ, Lanteri MC, Martin JN, Deeks SG, Ndhlovu LC.

AIDS Res Hum Retroviruses. 2014 Jul;30(7):654-64. doi: 10.1089/AID.2014.0004. Epub 2014 May 28.

46.

Increased levels of plasma galectin-9 in patients with influenza virus infection.

Katoh S, Ikeda M, Shimizu H, Mouri K, Obase Y, Kobashi Y, Fukushima K, Hirashima M, Oka M.

Tohoku J Exp Med. 2014 Apr;232(4):263-7.

47.

Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung.

Vega-Carrascal I, Bergin DA, McElvaney OJ, McCarthy C, Banville N, Pohl K, Hirashima M, Kuchroo VK, Reeves EP, McElvaney NG.

J Immunol. 2014 Mar 1;192(5):2418-31. doi: 10.4049/jimmunol.1300711. Epub 2014 Jan 29.

48.

Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.

Zhang Q, Luan H, Wang L, He F, Zhou H, Xu X, Li X, Xu Q, Niki T, Hirashima M, Xu G, Lv Y, Yuan J.

Am J Physiol Renal Physiol. 2014 Apr 15;306(8):F822-32. doi: 10.1152/ajprenal.00294.2013. Epub 2014 Jan 29.

49.

Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line.

Kojima R, Ohno T, Iikura M, Niki T, Hirashima M, Iwaya K, Tsuda H, Nonoyama S, Matsuda A, Saito H, Matsumoto K, Nakae S.

PLoS One. 2014 Jan 20;9(1):e86106. doi: 10.1371/journal.pone.0086106. eCollection 2014.

50.

Galectin-9 prolongs the survival of septic mice by expanding Tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophages.

Kadowaki T, Morishita A, Niki T, Hara J, Sato M, Tani J, Miyoshi H, Yoneyama H, Masaki T, Hattori T, Matsukawa A, Hirashima M.

Crit Care. 2013 Dec 9;17(6):R284. doi: 10.1186/cc13147.

Supplemental Content

Loading ...
Support Center